Find uplifting stories about heroes, innovations, and solutions
10982 results for "vaccine science"
America's largest physicians group is partnering with university researchers to provide independent, evidence-based vaccine guidance for families and doctors. The move comes as families seek trusted, science-backed information about vaccine decisions.
A federal judge ruled that science must guide childhood vaccine policy, blocking changes made without expert input. The decision validates what pediatricians have fought for: evidence-based protection for kids.
The scientist who helped create the first COVID-19 vaccine says the hardest part wasn't the research. It was earning trust from people with honest questions about what they were being asked to put in their bodies.
Seven in 10 Americans trust vaccine researchers to act in the public interest, matching confidence in other scientists. New polling shows trust in science remains strong even amid recent controversies.
Scientists explain why vaccines work like athletic training for your immune cells, preparing them to fight disease before you ever get sick. As measles outbreaks return to previously protected countries, understanding this science matters more than ever.
South Africa just unveiled an ambitious plan to build its own vaccine factories, green energy tech, and space programs while creating thousands of science jobs. The country is betting that homemade innovation can power its economy and reduce reliance on foreign systems.
Scientists developed a nasal spray vaccine that protected mice from COVID, flu, bacteria, and even allergens for months. Unlike typical vaccines, it activates the body's first-line defense system to fight multiple threats at once.
Researchers identified high-risk zones for yellow fever in Brazil's golden lion tamarins, creating a vaccination roadmap that could save this endangered species from future outbreaks. After losing 30% of their population in 2017-2019, the recovered tamarin population now has a science-backed protection plan.
South Africa is strengthening its global reputation through an ambitious 10-year science and innovation strategy focused on international partnerships and solving real-world problems. From vaccine manufacturing to climate research, the nation is positioning itself as a reliable partner bridging the Global North and South.
The same technology that revolutionized COVID vaccines just earned approval for seasonal flu, potentially ending decades of hit-or-miss protection. Moderna's mRNA flu shot marks a new era in how we fight one of America's most common infectious diseases.
Scientists are calling for more collaborations between artists and researchers to rebuild public confidence in science. The strategy comes as funding cuts threaten research programs worldwide.
A major Swedish study tracking nearly 60,000 women found no link between COVID-19 vaccination and reduced fertility, putting to rest persistent social media rumors. The research offers reassuring news for anyone who delayed vaccination due to pregnancy concerns.
Scientists just proved that an AI-designed vaccine can trigger a human immune response, marking the first time a computer-created vaccine has worked in people. This breakthrough could revolutionize how we develop vaccines for future diseases.
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
South Carolina's largest measles outbreak in decades has officially ended after nearly 1,000 cases, and there's encouraging news: vaccination rates are climbing both locally and nationwide. Health officials say the outbreak may have reminded parents why vaccines matter.
South Africa is preparing to roll out a groundbreaking tuberculosis vaccine for adults that could become the first new TB vaccine in over a century. The M72/AS01E vaccine is currently in Phase 3 trials across five countries and could help eliminate TB as a public health threat by 2030.
An FDA committee greenlighted next year's flu vaccine formulation this week, maintaining the proven update process while vaccine policy debates swirl in Washington. The decision keeps Americans on track for seasonal flu protection.
The same groundbreaking technology that created COVID vaccines just earned approval for fighting the flu. Moderna's new mRNA flu shot showed better protection than standard vaccines and will be available for the 2026-2027 flu season.
Scientists at Washington University have created a nose spray vaccine that completely protected mice and hamsters from bird flu infection, offering hope for preventing the next pandemic. The vaccine works better than traditional flu shots and stays effective even in people who've had previous flu vaccines.
A federal judge ruled that science-based procedures must guide vaccine recommendations, blocking recent changes made without expert input. The decision restores protections for the independent review process that has guided public health decisions for 60 years.
Showing 20 of 10982